Biotech investors and pharma companies have poured billions into three Boston-region startups competing to develop a next-generation version…
Nicotinamide adenine dinucleotide (NAD+) biosynthesis underlies many aspects of carcinogenesis. Inhibitors of nicotinamide phosphoribosyltransferase (NAMPT), which drives NAD+…